Haleon PLC (HLN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Haleon PLC (HLN) has a cash flow conversion efficiency ratio of 0.032x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX513.50 Million ≈ $62.48K USD) by net assets (GBX16.00 Billion ≈ $1.95 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Review HLN financial flexibility index to assess the company's free cash flow relative to its total liabilities.
Haleon PLC - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Haleon PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see HLN stock market capitalisation for the company's overall valuation and market capitalisation.
Haleon PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Haleon PLC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Quadient SA
PA:QDT
|
0.101x |
|
Monopar Therapeutics Inc
NASDAQ:MNPR
|
-0.026x |
|
Beijing InHand Networks Technology Co Ltd
SHG:688080
|
0.071x |
|
Somalogic Inc
NASDAQ:SLGC
|
-0.043x |
|
Mangalore Chemicals & Fertilizers Limited
NSE:MANGCHEFER
|
0.255x |
|
Zhangjiagang Zhonghuan Hailu High-End Equipment Co. Ltd.
SHE:301040
|
N/A |
|
Shanghai Fudan Forward S&T Co Ltd
SHG:600624
|
-0.048x |
|
Nanjing Inform Storage Equip
SHG:603066
|
-0.012x |
Annual Cash Flow Conversion Efficiency for Haleon PLC (2019–2024)
The table below shows the annual cash flow conversion efficiency of Haleon PLC from 2019 to 2024. View Haleon PLC stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | GBX16.22 Billion ≈ $1.97 Million |
GBX2.30 Billion ≈ $279.97K |
0.142x | +12.98% |
| 2023-12-31 | GBX16.73 Billion ≈ $2.04 Million |
GBX2.10 Billion ≈ $255.51K |
0.126x | +0.14% |
| 2022-12-31 | GBX16.46 Billion ≈ $2.00 Million |
GBX2.06 Billion ≈ $251.01K |
0.125x | +144.80% |
| 2021-12-31 | GBX26.48 Billion ≈ $3.22 Million |
GBX1.36 Billion ≈ $164.99K |
0.051x | -4.56% |
| 2020-12-31 | GBX26.22 Billion ≈ $3.19 Million |
GBX1.41 Billion ≈ $171.19K |
0.054x | +87.12% |
| 2019-12-31 | GBX27.41 Billion ≈ $3.34 Million |
GBX786.00 Million ≈ $95.63K |
0.029x | -- |
About Haleon PLC
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene… Read more